All Research on Pharmaceuticals and Healthcare in Japan

Insight

Report
Report

Immuno-Oncology Overview

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research.

Published By Datamonitor
$7500
Buy
Report
Report

Forecast: Rheumatoid Arthritis in the US, Japan, and 5EU

Datamonitor Healthcare uses a patient-based approach to size the rheumatoid arthritis (RA) market in the US, Japan, and five major EU markets from 2014 to 2023, focusing on traditional and biologic disease-modifying therapies.

Published By Datamonitor
$2800
Buy
Report
Report

Treatment: Rheumatoid Arthritis

Through our in-house primary research, Datamonitor Healthcare has produced thorough analysis on rheumatoid arthritis (RA) treatment trends, outcomes, and unmet needs.

Published By Datamonitor
$2800
Buy

View all Insight >>

Market Data

Interactive Model
Interactive Model

The Depression Market Forecast to 2021

The expected Q4 2013 launches of Brintellix and levomilnacipran will occur against a backdrop of a declining market.

Published By Datamonitor
$6400
Buy
Interactive Model
Interactive Model

The Hepatitis C Market Forecast to 2022

The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.

Published By Datamonitor
$6400
Buy
Interactive Model
Interactive Model

The Inflammatory Bowel Disease Market Forecast to 2021

The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.

Published By Datamonitor
$6400
Buy

View all Market Data >>

Profiles

Company Profile
Company Profile

Nihon Kohden Corporation

Nihon Kohden (Nihon or 'the company') is engaged in developing, manufacturing and selling medical electronics equipment. The company operates in Asia, Americas, Europe and other regions of the world. It is headquartered in Tokyo, Japan and employed 4,495 people as of March 31, 2014.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical (Chugai or 'the company'), the Japanese subsidiary of the Roche Group, is engaged in biopharmaceutical research and development. It produces antibody drugs primarily focusing on oncology, renal diseases and bone and joint diseases. The company operates in Japan, Switzerland and other regions of the world. It is headquartered in Tokyo, Japan, and employed 7,023 people as of December 31, 2014.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (Takeda or 'the company') is a research-based global company with its main focus on pharmaceuticals. The company markets its products in about 100 countries. It is headquartered in Osaka, Japan and employed 31,225 people as of March 31, 2014.

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.